RENAISSANCE TECHNOLOGIES LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in SUPN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$68,750,151
-$19,392,774 QoQ
Shares Held
1,478,180
-13.3% QoQ
Ownership
2.54%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#11
of 331 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,860,663 across 49 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,750,151 | 1,478,180 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $88,142,925 | 1,705,222 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $86,106,343 | 1,732,522 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $83,184,325 | 1,740,622 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $52,175,749 | 1,655,322 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $51,932,395 | 1,585,722 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $57,809,787 | 1,598,722 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $53,898,433 | 1,728,622 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $45,077,013 | 1,685,122 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $45,476,202 | 1,333,222 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $39,891,532 | 1,378,422 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $39,657,294 | 1,438,422 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $44,979,439 | 1,496,322 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $50,487,302 | 1,393,522 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $44,962,819 | 1,260,522 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $43,335,514 | 1,280,222 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $40,401,876 | 1,397,022 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $40,190,631 | 1,243,522 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $36,132,797 | 1,239,122 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $37,034,548 | 1,388,622 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $46,684,475 | 1,516,222 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $46,082,611 | 1,760,222 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $46,533,973 | 1,849,522 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $38,939,540 | 1,868,500 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $37,829,000 | 1,592,800 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $16,230,578 | 902,200 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||